Health Canada
- Status: approved
🇨🇦 bepotastine besilate, 1.5% in Canada
bepotastine besilate, 1.5% (bepotastine besilate, 1.5%) regulatory status in Canada.
Marketing authorisation
bepotastine besilate, 1.5% in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is bepotastine besilate, 1.5% approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for bepotastine besilate, 1.5% in Canada?
Southern California College of Optometry at Marshall B. Ketchum University is the originator. The local marketing authorisation holder may differ — check the official source linked above.